Broncho-munal P for children: instructions for use

If a child often has rhinitis, bronchitis or other diseases of the respiratory system, the doctor may recommend strengthening the body's defenses with a medication called Broncho-munal P. It differs from the usual “Broncho-munala” in half the dosage of active substances, therefore it can be prescribed in infants, even in infants. But before starting such a treatment, parents should learn more about its effects on the body and other nuances of use.

The drug is manufactured by the well-known company Sandoz only in capsules packed in blisters of 10 pieces. One package includes 1 or 3 such blisters, and the capsules themselves have an opaque gelatin shell and size 3. The body of the capsules is white, the cap is blue, and inside is a beige powder.

The main ingredient of this powder is the lysates of microorganisms, presented in a dosage of 3.5 mg in one capsule. In the structure of "Broncho-munala P" there are such destroyed bacteria:

• haemophilus sticks;
• Streptococcus viridans;
• pneumococci;
• pyogenic streptococci;
• Staphylococcus aureus;
• Klebsiella ozena and pneumonia;
• Moraxella cataris.

Inactive substances such as monosodium glutamate, starch and propyl gallate, as well as mannitol and magnesium stearate are added to them. The capsule shell is made of titanium dioxide, indigotin and gelatin.

The drug belongs to the immunostimulants, because under its influence activates the immune system of the patient. Lysates that enter the body penetrate the mucous membrane and affect B-lymphocytes. After increasing their amount in the blood, the production of antibodies is enhanced, and immunoglobulins are more actively synthesized. Lysates also affect immunity, called nonspecific. The result of the application of "Broncho-munala P" will be:

• reducing the frequency of SARS;
• reducing the duration of infection of the respiratory system;
• reducing the risk of exacerbations in chronic pathologies of the bronchi;
• increasing the resistance of the respiratory tract to pathogens;
• reducing the need for antibiotics and other drugs.

Since the components of "Broncho-munala P" are the causative agents of respiratory infections, the effect of the drug and concerns mainly the pathologies of the respiratory system. Capsules include the complex treatment of bronchitis, sinusitis, adenoiditis, rhinitis and other diseases. They are also often advised to take for prevention, for example, in children with chronic recurrent infections of the bronchi.

"Broncho-munal P" is intended for use in children, so you can see the mark "for children" on the box of capsules. The dosage of such capsules is suitable for young patients over 6 months to twelve years of age.

Teenagers over 12 years old are prescribed a drug without the letter “P” in the title, containing 7 mg of lysates in one capsule.

The drug is not used if the child has an intolerance to any of the components of the capsules. Broncho-munala P has no other contraindications, except for early age and hypersensitivity.

Usually, Bronchomunal P is tolerated without any negative symptoms, however, in some small patients, after taking the capsules, diarrhea or abdominal discomfort may appear.Sometimes the medication causes nausea, an allergic rash, headache or cough.

In some cases, the drug causes shortness of breath, vomiting, fever, angioedema, redness of the skin and other symptoms.

The capsule is recommended to give the child in the morning half an hour before breakfast (the remedy works best when used on an empty stomach). The standard dosage for both prevention and treatment is one capsule. If the baby still does not know how to swallow solid forms of the preparations, the gelatinous shell is opened, after which the powder is mixed with juice, milk or tea. The liquid is taken in a small amount so that the crumb immediately swallowed it.

According to the manufacturer, there were no cases of intoxication after taking too large a dose of “Broncho-munala P”. On the incompatibility of capsules with other drugs, too, no data. The drug can be used with any other medicines, including antibiotics.

“Broncho-munal P” refers to non-prescription drugs, but before buying such a drug, it is advisable for a child to consult with a pediatrician.

The average price of 10 capsules is 450-500 rubles, and for 30 capsules you need to pay about 1100-1200 rubles.

The shelf life of the drug - 5 years. Prior to its completion, Broncho-Munal P should be stored at a temperature of + 15 + 25 degrees, placing the drug in a dry place. In addition, it is recommended to keep the medicine where it will not be available for small children.

The use of Broncho-munala P in children, both for respiratory tract infections and for their prevention, is generally positive. Parents call the tool effective and praise for the possibility of use in small children, but complain about the high cost. In addition, there are reviews in which they note the absence of the therapeutic effect of the capsules.

As for doctors, some experts often prescribe such a medicine for children and note its effectiveness, while others, among whom Dr. Komarovsky, doubt the positive effect of Broncho-munala P on immunity. They believe that Improved resistance to infections is much better with the correct daily regimen, a sufficient level of activity of the child and a balanced diet.

Replacement "Broncho-munalu P" can serve as a drug called "Broncho-Vaks children". It is also represented by capsules, inside of which there are lysates of the same microorganisms and in the same dosage. Drugs are similar in appearance (the same color and size of capsules), and the composition of excipients.

They differ only in the manufacturer, which affects the cost of the drug. Broncho-Vaks is produced in Switzerland and costs a little more expensive - 530-560 rubles for 10 capsules and 1300-1400 rubles for 30 capsules.

Both of these drugs can also be replaced by other drugs that act on the immune system by the same mechanism and contain destroyed bacteria or parts of them. These tools include:

• Pills «Ismigen»that need to keep under the tongue until dissolved. They are used from the age of three.
• Spray «IRS 19»approved for use in babies older than three months. It is sprayed in the nasal cavity.
• Pills «Imudon»designed for resorption in the mouth. They are used in the treatment of patients older than 3 years.
• Granules or tablets «Ribomunil». They are used for otitis, sinusitis, tracheitis and other diseases in children older than six months.

Dr. Komarovsky will tell you about antiviral drugs in the next video.